Meligy, F.Y.; El-Deen Mohammed, H.S.; Mostafa, T.M.; Elfiky, M.M.; El-Sayed Mohamed Ashry, I.; Abd-Eldayem, A.M.; Rizk, N.I.; Sabry, D.; Abd Allah, E.S.H.; Ahmed, S.F.
RETRACTED: Meligy et al. Therapeutic Potential of Mesenchymal Stem Cells Versus Omega n − 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration. Pharmaceutics 2022, 14, 1322. Pharmaceutics 2026, 18, 801.
https://doi.org/10.3390/pharmaceutics18070801
AMA Style
Meligy FY, El-Deen Mohammed HS, Mostafa TM, Elfiky MM, El-Sayed Mohamed Ashry I, Abd-Eldayem AM, Rizk NI, Sabry D, Abd Allah ESH, Ahmed SF.
RETRACTED: Meligy et al. Therapeutic Potential of Mesenchymal Stem Cells Versus Omega n − 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration. Pharmaceutics 2022, 14, 1322. Pharmaceutics. 2026; 18(7):801.
https://doi.org/10.3390/pharmaceutics18070801
Chicago/Turabian Style
Meligy, Fatma Y., Hanan Sharaf El-Deen Mohammed, Tarek M. Mostafa, Mohamed M. Elfiky, Israa El-Sayed Mohamed Ashry, Ahmed M. Abd-Eldayem, Nermin I. Rizk, Dina Sabry, Eman S. H. Abd Allah, and Salwa Fares Ahmed.
2026. "RETRACTED: Meligy et al. Therapeutic Potential of Mesenchymal Stem Cells Versus Omega n − 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration. Pharmaceutics 2022, 14, 1322" Pharmaceutics 18, no. 7: 801.
https://doi.org/10.3390/pharmaceutics18070801
APA Style
Meligy, F. Y., El-Deen Mohammed, H. S., Mostafa, T. M., Elfiky, M. M., El-Sayed Mohamed Ashry, I., Abd-Eldayem, A. M., Rizk, N. I., Sabry, D., Abd Allah, E. S. H., & Ahmed, S. F.
(2026). RETRACTED: Meligy et al. Therapeutic Potential of Mesenchymal Stem Cells Versus Omega n − 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration. Pharmaceutics 2022, 14, 1322. Pharmaceutics, 18(7), 801.
https://doi.org/10.3390/pharmaceutics18070801
